New Bacteriophages Members of the Ackermannviridae Family Specific for Klebsiella pneumoniae ST258

Estefanía Tisalema-Guanopatín, Fausto Cabezas-Mera, Karla Nolivos-Rodríguez, Isabel Fierro, Lourdes Pazmiño, Daniel Garzon-Chavez, Alexis Debut, Karla Vizuete, Jorge Aníbal Reyes

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Background: Carbapenem-resistant Klebsiella pneumoniae, particularly isolates classified as sequence-type 258 (ST258), are multidrug-resistant strains that are strongly associated with poor-prognosis nosocomial infections, as current therapeutic options are limited and ineffective. In recent years, phage therapy has emerged as a promising treatment option for these scenarios. Methodology and Results: We report the isolation and characterization of three new phages against Klebsiella pneumoniae ST258 strains recovered from Machángara river wastewater. These new members of the Ackermannviridae family showed stability over a wide temperature and pH range and burst sizes ranging from 6 to 44 plaque-forming units per bacteria. Their genomes were about 157 kilobases, with an average guanine-cytosine content of 46.4% and showed presence of several transfer RNAs, which also allowed us to predict in silico a lytic replicative cycle due to the presence of endolysins and lysozymes. Conclusion: Three lytic phages of Ackermannviridae family were recovered against Klebsiella pneumoniae ST258 strains from sewage; however, further characterization is needed for future consideration as therapeutic alternatives.

Idioma originalInglés
Páginas (desde-hasta)99-107
Número de páginas9
PublicaciónPHAGE: Therapy, Applications, and Research
Volumen4
N.º2
DOI
EstadoPublicada - 1 jun. 2023

Huella

Profundice en los temas de investigación de 'New Bacteriophages Members of the Ackermannviridae Family Specific for Klebsiella pneumoniae ST258'. En conjunto forman una huella única.

Citar esto